- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02756780
Tenovus Cancer Choirs Study: the Benefits of Singing for Those Affected by Cancer
Tenovus Cancer Choirs: the Effect of Choir Singing on Psychological and Immune Responses of Cancer Patients, Staff and Carers
Study Overview
Detailed Description
There is growing evidence that psychosocial interventions from mindfulness to yoga to the arts can reduce symptoms of depression and anxiety, increase social support networks, improve quality of life and raise perceptions of care in people affected by cancer 1,2. These positive states have, in turn, been linked with optimised immune responses including reduced stress hormones and enhanced cellular activity 1,3,4. However, despite growing numbers of music interventions for cancer care, there is little research into their psychobiological impact.
'Sing With Us' choirs are an initiative established in Wales by Tenovus Cancer Care to provide social support and improve mental wellbeing amongst those affected by cancer, whether patients, carers or staff. Research has already demonstrated that these choirs can reduce depression and anxiety amongst participants and improve social support networks and quality of life as well as preliminary evidence that they can reduce levels of stress hormones and enhance immune activity 5,6. The aim of this study is to establish more about the psychological benefits of regular choir singing and explore whether the biological changes noted in pilot studies can be sustained over time. This could identify whether choirs have the potential to optimise health in people affected by cancer, helping to put patients in the best position to receive treatment or maintain re mission and supporting those who care for someone with cancer, whether professionally or informally.
As part of this project, and in addition to the choirs already run by Tenovus Cancer Care, Tenovus will fund two choirs, one at each of the Royal Marsden sites. These will run on a weekly basis for 18 months and will consist of a session lasting 1 hour led by a professional choir leader who is a member of the Tenovus Cancer Care staff. The choirs will be open to anybody affected by cancer at the Royal Marsden Hospital or in the local area. However, there will be three cohorts of patients involved in the research running alongside the choir: cohorts A and B involving active recruitment of participants and Cohort C in which people who join the choir of their own volition but are not eligible for the first 3 cohorts will be invited to participate:
Cohort A: breast, prostate and colorectal cancer patients will be invited to join the study for a period of 12 weeks. If they are able to make the dates and times of the choir sessions they will become part of the experimental group. If they are unable to make the dates and times or live too far away but fulfil all the same criteria (including expressing an interest in singing) they will become part of the control group. Data collection for all participants will include (a) completing psychological scales which will be available in hard copy or as online versions; (b) providing saliva samples before 4 choir rehearsals: week 1, week 6 and week 12 with a three month follow-up (week 24). Experimental participants will be expected to attend as many of the first 12 choir sessions in the time period as possible but will then select whether they continue involvement in the choir for the following 12 weeks.
Cohort B: hospital staff, carers of somebody affected by cancer and bereaved carers will be invited to join the study for a period of 12 weeks. Recruitment and participation for this Cohort (including the presence of a control group) will be as in Cohort A except there will be no biological component. Participants will merely complete the online psychological questionnaires.
Cohort C: all other participants who decide to join the choirs (whether patients, carers or staff) will be invited to take part in the psychological part of the study, completing the anonymous questionnaires at weeks 0, 6, 12 and 24. This will be an uncontrolled Cohort. But it may identify additional participant groups for whom the choirs provide support.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
London/Surrey, United Kingdom
- Recruiting
- Royal Marsden Hospital NHS Foundation Trust
-
Contact:
- Theresa Wiseman, PhD
-
Principal Investigator:
- Theresa Wiseman, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- COHORT A: (i) Patients with stage I-III breast cancer up to 24 months post diagnosis
- (ii) Patients with diagnosed prostate cancer on active surveillance
- (iii) Patients with colorectal cancer stages I-III up to 24 months post diagnosis
- COHORT B: (i) Members of staff at a hospital
- (ii) People who care for somebody with cancer, whether formally or informally
- (iii) People who have lost a family member or somebody they cared for to cancer in the last 3 years
- COHORT C: anybody who is affected by cancer and has joined the choir
General exclusion Criteria:
- Participants aged under the age of 18
- Level of English insufficient to provide informed consent or complete the psychological questionnaires
- Refusal to participate
- Already engaged in a weekly group choir
- Started a formal course of psychological therapy in the past 1 month or scheduled to start in the next 12 weeks
- Started any new medication for anxiety or depression in the last month
Additional exclusion criteria for cohort A:
- Currently having chemotherapy or radiotherapy or less than 90 days since last session
- Scheduled for surgery in the next 12 weeks or less than 90 days post surgery
- Have a current diagnosis of an additional immune condition e.g. lupus
- Currently being treated with steroids or immunosuppressive medication
- Participants who are pregnant
Study Plan
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Tenovus Cancer Choir
Participants will be asked to attend 12 weeks of weekly choir rehearsals lasting approximately 1 hour.
Following the first 12 weeks, participants will no longer be asked to attend rehearsals, but are welcome to do so.
Whether or not they do and how many they attend will be measured as an outcome variable to assess whether initial 3-month involvement leads to long-term engagement.
|
Choir sessions will take place at both of the Royal Marsden Hospital sites on a weekly basis.
Sessions typically consist of learning popular songs with messages of support.
Songs are learnt without sheet music, using specially created backing tracks.
These are also made available to participants at home so they can continue singing away from the sessions.
No singing experience is required and the main aim of the sessions is enjoyment and meeting other people.
Sessions will take place in the early evening so that participants have the option of staying to socialise afterwards.
|
|
No Intervention: Control (no choir) Group
If eligible participants are unable to make the dates and times or live too far away but fulfil all the same criteria (including expressing an interest in singing) they will become part of the control group.
This will involve the same data collection as the Cancer Choir Group but participants will not sing in a weekly choir.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Anxiety & Depression
Time Frame: Change in anxiety and depression level at weeks 6, 12 and 24 compared to baseline
|
Hospital Anxiety and Depression Scale (HADS)
|
Change in anxiety and depression level at weeks 6, 12 and 24 compared to baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Social Support
Time Frame: Change in social provision level at weeks 6, 12 and 24 compared to baseline
|
Social Provisions Scale (SPS)
|
Change in social provision level at weeks 6, 12 and 24 compared to baseline
|
|
Wellbeing
Time Frame: Change in wellbeing level at weeks 6, 12 and 24 compared to baseline
|
Warwick-Edinburgh Short Questionnaire (WEMWBS)
|
Change in wellbeing level at weeks 6, 12 and 24 compared to baseline
|
|
Self-efficacy
Time Frame: Change in self-efficacy level at weeks 6, 12 and 24 compared to baseline
|
General Self-Efficacy scale short form (GSE-6)
|
Change in self-efficacy level at weeks 6, 12 and 24 compared to baseline
|
|
Self-esteem
Time Frame: Change in self-esteem level at weeks 6, 12 and 24 compared to baseline
|
Sing Item Self-Esteem Scale
|
Change in self-esteem level at weeks 6, 12 and 24 compared to baseline
|
|
General Health
Time Frame: Change in general health level at weeks 6, 12 and 24 compared to baseline
|
Short Form 12 Health Survey (SF12)
|
Change in general health level at weeks 6, 12 and 24 compared to baseline
|
|
Stress hormones
Time Frame: Change in stress hormone levels at weeks 6, 12 and 24 compared to baseline
|
Salivary cortisol levels
|
Change in stress hormone levels at weeks 6, 12 and 24 compared to baseline
|
|
Immune proteins
Time Frame: Change in immune protein levels at weeks 6, 12 and 24 compared to baseline
|
Saliva cytokines, chemokines and receptors
|
Change in immune protein levels at weeks 6, 12 and 24 compared to baseline
|
Collaborators and Investigators
Investigators
- Principal Investigator: Theresa Wiseman, PhD, Royal Marsden NHS Foundation Trust
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- SWU2016
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
Second Affiliated Hospital of Soochow UniversityNot yet recruitingCancer | Solid Cancer
-
New Mexico Cancer Research AllianceOhio State University Comprehensive Cancer Center; H. Lee Moffitt Cancer Center...RecruitingCancer | Cancer RiskUnited States
-
Children's Hospital of PhiladelphiaCompletedCancer | Childhood CancerUnited States
-
University of California, San FranciscoBristol-Myers Squibb; PfizerTerminatedStage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Metastatic Colorectal Adenocarcinoma | Metastatic Colon Adenocarcinoma | Metastatic Rectal Adenocarcinoma | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Stage IV Colon Cancer | Stage IV Rectal... and other conditionsUnited States
Clinical Trials on Tenovus Cancer Choir
-
Toronto Metropolitan UniversityMitacs; Sonova AGTerminatedAging | Hearing Loss | Music Therapy | Auditory PerceptionCanada
-
University of Southern CaliforniaCompleted
-
University of OttawaUniversity of South Florida; Université du Québec à Trois-Rivières; Université... and other collaboratorsRecruitingAphasiaUnited States, Canada
-
University of Southern CaliforniaRecruitingAnxiety | Social Behavior | Speech PerceptionUnited States
-
NORCE Norwegian Research Centre ASUniversity of Nottingham; University Medical Center Groningen; University of... and other collaboratorsCompletedDepression | DementiaUnited Kingdom, Australia, Germany, Netherlands, Norway, Turkey
-
University of California, San FranciscoSan Francisco Community Music Center; Department of Aging and Adults Services...CompletedWell BeingUnited States
-
Stockholm UniversityThe Swedish Research Council; Region StockholmCompletedIrritable Bowel SyndromeSweden
-
Norwegian Academy of MusicUniversity of Oslo; Oslo Municipality; Institute of Clinical Medicine, University...Active, not recruitingDementia | Informal Caregivers (Family and Friends)Norway
-
Iolanda Costa GalinhaDGArtes - Direção Geral das Artes; CIS-Iscte - Centro de Investigação e Intervenção...CompletedDepression | Quality of Life | Body Weight | Stress | Sleep | Anxiety | Blood Pressure | Cognitive Function | Blood Glucose | Loneliness | Physical Function | Medication Compliance | Balance | Memory | Biomarker | Well-Being | Respiratory Function | Social Identification | Cholesterol | C-reactive Protein | Erythrocyte Sedimentation Rate and other conditionsPortugal
-
Beijing Friendship HospitalRecruitingGastric Cancer | Esophagus CancerChina